104 related articles for article (PubMed ID: 9369408)
1. Ifosfamide/cisplatin-based chemotherapy in metastatic undifferentiated nasopharyngeal carcinoma.
Stein ME; Drumea K
Laryngoscope; 1997 Nov; 107(11 Pt 1):1559. PubMed ID: 9369408
[No Abstract] [Full Text] [Related]
2. A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa.
Stein ME; Ruff P; Weaving A; Fried J; Bezwoda WR
Am J Clin Oncol; 1996 Aug; 19(4):386-8. PubMed ID: 8677911
[TBL] [Abstract][Full Text] [Related]
3. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.
Altundag K; Aksoy S; Gullu I; Altundag O; Ozyar E; Yalcin S; Cengiz M; Akyol F
Med Oncol; 2004; 21(3):211-5. PubMed ID: 15456947
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
5. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
6. Combined chemotherapy for recurrent and metastatic nasopharyngeal carcinoma.
Airoldi M; Pedani F; Gabriele P; Giordano C; Cavalot A; Brando V
J Chemother; 1989 Aug; 1(4):272-6. PubMed ID: 2809696
[TBL] [Abstract][Full Text] [Related]
7. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
[TBL] [Abstract][Full Text] [Related]
8. Choroid metastasis of undifferentiated nasopharyngeal carcinoma.
Ozyar E; Kiratli H; Akbulut S; Uzal D; Atahan IL
J Laryngol Otol; 1998 Jul; 112(7):667-9. PubMed ID: 9775302
[TBL] [Abstract][Full Text] [Related]
9. Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma - How far have we achieved?
Lee V; Kwong D; Leung TW; Lam KO; Tong CC; Lee A
Crit Rev Oncol Hematol; 2017 Jun; 114():13-23. PubMed ID: 28477740
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy with doxorubicin and CCNU in advanced undifferentiated carcinoma of the nasopharynx. A retrospective report on five patients.
de Graeff A; de Groot JA; Schornagel JH
Neth J Med; 1987 Oct; 31(3-4):111-6. PubMed ID: 3683681
[No Abstract] [Full Text] [Related]
11. [Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum].
Penel N; Kouto H; Ala-Eddine C; Degardin M
Rev Med Interne; 2002 Mar; 23(3):337-9. PubMed ID: 11928386
[No Abstract] [Full Text] [Related]
12. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.
Fandi A; Bachouchi M; Azli N; Taamma A; Boussen H; Wibault P; Eschwege F; Armand JP; Simon J; Cvitkovic E
J Clin Oncol; 2000 Mar; 18(6):1324-30. PubMed ID: 10715304
[TBL] [Abstract][Full Text] [Related]
13. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
Dede DS; Aksoy S; Cengiz M; Gullu I; Altundag K
Asian Pac J Cancer Prev; 2012; 13(5):2225-8. PubMed ID: 22901198
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: a retrospective analysis of 519 patients: a single institution experience.
Pai VR; Mazumdar AT; Deshmukh CD; Bakshi AV; Parikh DM; Parikh PM; Mistry RC; Pathak KA
Med Oncol; 2003; 20(1):1-5. PubMed ID: 12665677
[TBL] [Abstract][Full Text] [Related]
16. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Oral Oncol; 2005 Jul; 41(6):589-95. PubMed ID: 15975521
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
Chen M; Lin S; Zheng W
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
[TBL] [Abstract][Full Text] [Related]
19. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
de Crevoisier R; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
[No Abstract] [Full Text] [Related]
20. Metastatic nasopharyngeal carcinoma outcomes in patients on cisplatin with nolatrexed or 5-fluorouracil.
Zheng J; Lin J; Wang L; Zhou J; Xie B; Xu T; Zhang W
Oncol Res Treat; 2014; 37(10):540-4. PubMed ID: 25342504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
